7 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.

The Scripps Research Institute-Florida
The development of N-a-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-a-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

The Scripps Research Institute
Peptidylarginine deiminases 4 as a promising target in drug discovery.

Zhejiang Ocean University
Cellular Activity of New Small Molecule Protein Arginine Deiminase 3 (PAD3) Inhibitors.

Yale University
Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.

University Health Network
Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple Sclerosis.

University of Toronto